This study is in progress, not accepting new patients
A Study of Volixibat to Treat Itching Caused by Primary Sclerosing Cholangitis
Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!
Summary
- Eligibility
- for people ages 12 years and up (full criteria)
- Location
- at UC Davis
- Dates
- study startedstudy ends around
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Mirum Pharmaceuticals, Inc.
- ID
- NCT04663308
- Phase
- Phase 2 research study
- Study Type
- Interventional
- Participants
- About 182 people participating
- Last Updated